CHRISTOPHER, RONALD J,OGAWA, ATSUSHI,COVINGTON, PAUL
申请号:
NZ57552107
公开号:
NZ575521A
申请日:
2007.09.11
申请国别(地区):
NZ
年份:
2012
代理人:
摘要:
Disclosed is the use of 2-[6-(3-Amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2Hpyrimidin-1-ylmethyl]-4-fluoro-benzonitrile (as pictured) in the production of a medicament for the treatment of diabetes, wherein the medicament is adapted to be administered at a weekly dose of between 1 mg and 250 mg once per week.